Clinical Trial Update: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

View source ↗

Summary

This clinical trial update investigates using exhaled breath analysis with eNose technology as a biomarker for diagnosing and monitoring progression in fibrotic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Snippet

Sponsor: Erasmus Medical Center | Conditions: Pulmonary Fibrosis | Status: ACTIVE_NOT_RECRUITING